Family Medicine · Brooklyn, NY
NPI
1972677516
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3304 Glenwood Road
Brooklyn, NY, 11210
Phone (718) 859-0008
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
1,618 services
Medicare patients, 2024
66
Average age 76
Drug cost, 2024
$1.3M
5,644 prescriptions
Company payments, 2025
$2,085
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Walford B Lindo was code 82962 (clinical chemistry), 281 times for 66 patients. In total Walford B Lindo billed 1,618 services in 29 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 281 | 66 | $3.21 | $902 |
| 99214 Office E&M - Established | Office | 278 | 66 | $94.18 | $26K |
| 82947 Clinical Chemistry | Office | 272 | 66 | $3.85 | $1,047 |
| 83036 Blood Count | Office | 151 | 65 | $9.52 | $1,438 |
| 96372 Injection Administration | Office | 82 | 50 | $12.73 | $1,044 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 82 | 21 | $28.38 | $2,327 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 77 | 49 | $0.86 | $66.3 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 56 | 56 | $147.28 | $8,248 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 55 | 55 | $28.37 | $1,560 |
| G0008 Administration of influenza virus vaccine | Office | 42 | 42 | $37.09 | $1,558 |
| 90653 Vaccine Product | Office | 38 | 38 | $81.82 | $3,109 |
| 96160 E&M - Miscellaneous | Office | 38 | 38 | $2.37 | $90.04 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 35 | 35 | $21.70 | $759 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 35 | 35 | $21.70 | $759 |
| 80061 Clinical Chemistry | Office | 24 | 21 | $13.12 | $315 |
By year: 2022 $63K for 1,973 services; 2023 $63K for 1,788 services; 2024 $52K for 1,618 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 281 | 66 | $3.21 | $902 |
| 82947 Clinical Chemistry | 272 | 66 | $3.85 | $1,047 |
| 83036 Blood Count | 151 | 65 | $9.52 | $1,438 |
| 80061 Clinical Chemistry | 24 | 21 | $13.12 | $315 |
Medicare prescription drug claims, 2024
In 2024, the drug Walford B Lindo prescribed most often to Medicare patients was Amlodipine Besylate, with 390 prescriptions and refills. In total Walford B Lindo wrote 5,644 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 390 | 1,113 | 119 | $2,332 |
| Vascepa Icosapent Ethyl | 290 | 637 | 91 | $206K |
| Ezetimibe Generic | 284 | 788 | 85 | $5,367 |
| Simvastatin Generic | 232 | 667 | 67 | $1,964 |
| Hydrochlorothiazide Generic | 219 | 650 | 74 | $601 |
| Rosuvastatin Calcium Generic | 219 | 614 | 75 | $3,214 |
| Niacin Er Niacin | 199 | 558 | 65 | $11K |
| Atorvastatin Calcium Generic | 188 | 531 | 52 | $1,828 |
| Candesartan Cilexetil Generic | 172 | 463 | 48 | $8,592 |
| Valsartan Generic | 144 | 429 | 50 | $4,738 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 129 | 383 | 39 | $1,373 |
| Levothyroxine Sodium Generic | 123 | 367 | 36 | $1,341 |
| Ozempic Semaglutide | 119 | 144 | 19 | $134K |
| Metoprolol Succinate Generic | 114 | 322 | 33 | $1,847 |
| Losartan Potassium Generic | 112 | 313 | 32 | $1,177 |
Brand drugs: 1,420 claims; generic drugs: 4,136 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Walford B Lindo $2,085 ($2,085 in general payments such as food, travel and fees) from 10 companies. The largest payer was Novo Nordisk Inc with $763.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $763 |
| Amgen Inc. AMGN | 10 | $429 |
| Lilly USA, LLC LLY | 10 | $259 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $160 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $120 |
| Pfizer Inc. PFE | 4 | $90.34 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $68.11 |
| Exact Sciences Corporation EXAS | 2 | $51.99 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $18.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.